Jade Biosciences (JBIO) Cash from Investing Activities (QoQ) (2021 - 2026)
Jade Biosciences (JBIO) Cash from Investing Activities (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Jade Biosciences | 1.18 Bn | 866.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.37% |
| Dec 31, 2025 | 33.99% |
| Sep 30, 2025 | -1,045.14% |
| Jun 30, 2025 | -201.06% |
| Mar 31, 2025 | -2.13% |
| Mar 31, 2024 | 56.39% |
| Dec 31, 2023 | 143.02% |
| Sep 30, 2023 | -429.65% |
| Jun 30, 2023 | -74.09% |
| Mar 31, 2023 | 6.14% |
| Dec 31, 2022 | 211.86% |
| Sep 30, 2022 | -43.31% |
| Jun 30, 2022 | 140.17% |
| Mar 31, 2022 | 82.00% |
| Dec 31, 2021 | -202,289.29% |